Shands Teaching Hospital and Clinics INC

Shands Teaching Hospital and Clinics INC was paid $92.02M by Medicaid between Jan 2018 and Dec 2024, across 794 billing codes. Its largest line is 99284, emergency room visit (serious) — 5.8% of everything it billed.

33Billing provider infoSHANDS TEACHING HOSPITAL AND CLINICS INC
GAINESVILLE, FL 32610

33aNPI1699874248assigned 09/21/2006

33bProvider typeLand Ambulance

28Total paid$92.02M

24GClaims3,058,553

24DCodes billed794

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Land Ambulance providers in Florida

Rank by total paid#2 of 87

Median peer was paid$558K

This provider vs. median165×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	230,046	$3.84M
2019	537,822	$16.41M
2020	567,740	$16.44M
2021	662,277	$18.57M
2022	734,187	$22.94M
2023	248,723	$9.71M
2024incomplete	77,758	$4.11M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	5.8%	66,949	58,322	$5.37M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	5.1%	70,453	63,824	$4.68M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	4.1%	33,531	27,826	$3.73M
97530	Therapeutic activities, direct patient contact, each 15 minutes	3.8%	65,514	23,047	$3.46M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	3.2%	63,494	26,715	$2.93M
80053	Comprehensive metabolic panel	2.7%	100,322	74,253	$2.51M
96361	Intravenous infusion, hydration; each additional hour	2.3%	22,947	18,015	$2.07M
54161		2.2%	2,455	2,326	$2.04M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	1.9%	21,706	8,008	$1.74M
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	1.8%	16,652	15,708	$1.69M
77386		1.6%	7,220	573	$1.52M
42820	Tonsillectomy and adenoidectomy; younger than age 12	1.6%	1,454	1,386	$1.49M

782 more codes

93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.6%	8,350	$1.46M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	1.6%	2,986	$1.43M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.5%	19,207	$1.37M
96375	Therapeutic injection; each additional sequential IV push	1.5%	36,803	$1.36M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.5%	15,256	$1.34M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.4%	16,473	$1.29M
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	1.2%	3,181	$1.09M
36415	Collection of venous blood by venipuncture	1.1%	32,524	$1.04M
95810	Polysomnography; sleep staging with 4 or more additional parameters	1.1%	2,312	$1.02M
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	1.1%	1,848	$981K
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.0%	14,642	$942K
93304		<1%	3,062	$920K
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	991	$847K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	5,100	$835K
41899	Unlisted procedure, dentoalveolar structures	<1%	1,810	$825K
70450	Computed tomography, head or brain; without contrast material	<1%	12,677	$817K
80048	Basic metabolic panel (calcium, ionized)	<1%	58,816	$814K
97162		<1%	10,066	$796K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	8,419	$771K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	35,116	$765K
92557		<1%	9,559	$760K
95782		<1%	1,342	$690K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	11,327	$659K
97116		<1%	11,746	$657K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	4,902	$635K
J9312	Injection, rituximab, 10 mg	<1%	849	$606K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	15,429	$604K
94060		<1%	7,999	$571K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	31,604	$535K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	3,485	$511K
J9271	Injection, pembrolizumab, 1 mg	<1%	642	$507K
86850		<1%	15,537	$503K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	164,500	$498K
97535	Self-care/home management training, each 15 minutes	<1%	12,139	$485K
96415		<1%	5,592	$469K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	10,033	$441K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	4,446	$419K
71046	Radiologic examination, chest; 2 views	<1%	32,379	$411K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	3,531	$407K
G0378	Hospital observation service, per hour	<1%	6,806	$406K
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	<1%	971	$405K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	16,766	$369K
76775		<1%	6,430	$353K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	7,152	$343K
77336		<1%	3,190	$338K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	2,051	$333K
93308		<1%	2,779	$326K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	2,419	$318K
92552		<1%	4,254	$302K
97166		<1%	4,629	$299K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	12,703	$287K
92579		<1%	4,893	$283K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	7,471	$273K
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	<1%	15,819	$268K
73564		<1%	9,753	$260K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	4,254	$258K
97163		<1%	3,292	$249K
94010		<1%	7,363	$249K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	2,093	$242K
A9270	Non-covered item or service	<1%	21,362	$236K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,079	$225K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	2,680	$223K
70491		<1%	2,324	$209K
71275	Computed tomographic angiography, chest, with contrast material	<1%	5,134	$203K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	6,656	$201K
73110		<1%	7,906	$198K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	52,348	$198K
97113		<1%	4,266	$198K
73610		<1%	7,812	$197K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	767	$196K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	673	$188K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	3,631	$188K
42830		<1%	101	$186K
76830	Ultrasound, transvaginal	<1%	4,416	$186K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	2,566	$179K
78264		<1%	1,016	$178K
95812		<1%	648	$176K
73130		<1%	7,051	$175K
97165		<1%	2,078	$173K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	6,833	$170K
82947		<1%	23,956	$170K
78816		<1%	1,248	$169K
74183		<1%	1,381	$167K
95811		<1%	510	$166K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	7,869	$164K
97161		<1%	2,186	$161K
96402		<1%	1,264	$161K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	15,301	$161K
71250		<1%	5,142	$161K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	45,469	$156K
83735		<1%	46,473	$155K
74230		<1%	1,844	$153K
73030		<1%	7,809	$152K
86900		<1%	17,477	$152K
96368		<1%	1,960	$151K
36430		<1%	2,372	$148K
76536		<1%	2,783	$147K
J3490	Unclassified drugs	<1%	41,109	$145K
76825		<1%	838	$145K
73630		<1%	7,948	$140K
96367		<1%	2,807	$137K
70496		<1%	2,087	$137K
A0434	Specialty care transport (sct)	<1%	588	$136K
74018		<1%	5,404	$133K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	5,747	$129K
72082		<1%	2,907	$129K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	582	$129K
73140		<1%	4,179	$128K
72141		<1%	1,628	$128K
87070		<1%	5,926	$125K
J2704	Injection, propofol, 10 mg	<1%	39,168	$123K
92523		<1%	971	$121K
80069		<1%	5,072	$120K
76642		<1%	3,071	$118K
64493		<1%	418	$116K
87086	Culture, bacterial; quantitative colony count, urine	<1%	19,088	$115K
92567		<1%	17,368	$114K
16020		<1%	1,329	$112K
84484		<1%	36,368	$111K
73100		<1%	3,369	$110K
73590		<1%	5,049	$109K
99213	Doctor's office visit, returning patient (routine)	<1%	2,165	$109K
70487		<1%	2,003	$108K
84100		<1%	34,977	$107K
73090		<1%	4,535	$102K
87081		<1%	8,221	$102K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	29,615	$99K
81001		<1%	37,231	$99K
73070		<1%	3,900	$98K
93798		<1%	1,703	$98K
95816		<1%	639	$97K
86141		<1%	27,717	$96K
64483		<1%	458	$95K
73560		<1%	5,850	$95K
78815	Positron emission tomography (PET) for limited area imaging	<1%	280	$93K
84443	Thyroid stimulating hormone (TSH)	<1%	18,493	$93K
88307		<1%	2,352	$91K
89051		<1%	1,283	$91K
J0490	Injection, belimumab, 10 mg	<1%	78	$91K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,512	$91K
80076		<1%	7,623	$89K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	22,400	$88K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,982	$84K
72197		<1%	891	$83K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	9,049	$82K
71045	Radiologic examination, chest; single view	<1%	12,956	$82K
92553		<1%	717	$82K
93325		<1%	11,029	$81K
80197		<1%	11,954	$80K
93976		<1%	5,075	$80K
72100		<1%	3,977	$79K
L3906	Wrist hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment	<1%	818	$79K
83605		<1%	14,220	$78K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	18,935	$77K
85610		<1%	21,030	$77K
81025		<1%	19,185	$77K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	494	$76K
C1769	Guide wire	<1%	6,386	$75K
77300		<1%	1,126	$75K
87077		<1%	11,989	$74K
83690		<1%	21,424	$73K
74174		<1%	921	$73K
83880		<1%	15,119	$73K
87507		<1%	556	$73K
93971		<1%	3,805	$71K
70543		<1%	424	$71K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	3,268	$71K
J1644	Injection, heparin sodium, per 1000 units	<1%	9,303	$71K
11043		<1%	681	$70K
86832		<1%	1,768	$70K
J1602	Injection, golimumab, 1 mg, for intravenous use	<1%	55	$68K
36592		<1%	10,668	$68K
74240		<1%	1,010	$68K
74178		<1%	1,080	$67K
82728		<1%	12,082	$67K
62323		<1%	154	$66K
72040		<1%	2,264	$66K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	13,555	$66K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,328	$65K
70486		<1%	1,755	$65K
36591		<1%	5,047	$65K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	406	$65K
73502		<1%	4,162	$64K
92587		<1%	6,038	$63K
87497		<1%	7,116	$63K
97542		<1%	1,207	$63K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	3,021	$61K
70480		<1%	831	$60K
93970		<1%	2,084	$60K
97167		<1%	824	$59K
77301		<1%	134	$59K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	14,448	$59K
96409		<1%	1,539	$58K
77066	Tomosynthesis, mammo	<1%	1,804	$57K
64635		<1%	293	$57K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	1,298	$56K
77334		<1%	1,148	$55K
20680		<1%	42	$55K
73080		<1%	1,785	$55K
85027		<1%	16,937	$55K
73221		<1%	541	$54K
93356		<1%	964	$53K
80047		<1%	3,201	$53K
93017		<1%	1,256	$52K
93923		<1%	1,393	$52K
L3913	Hand finger orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment	<1%	450	$50K
86901		<1%	17,621	$50K
80061	Lipid panel	<1%	9,500	$50K
97597		<1%	1,079	$49K
27447		<1%	15	$48K
73552		<1%	3,074	$48K
93226		<1%	1,090	$48K
73521		<1%	1,580	$48K
49452		<1%	553	$47K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	22,058	$46K
L3808	Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment	<1%	539	$46K
J0690	Injection, cefazolin sodium, 500 mg	<1%	9,966	$43K
72170		<1%	2,401	$43K
73000		<1%	1,243	$43K
72125	Computed tomography, cervical spine; without contrast material	<1%	5,375	$42K
93271		<1%	1,063	$42K
93922		<1%	744	$41K
82248		<1%	25,119	$41K
82803		<1%	3,796	$41K
43235		<1%	280	$41K
73600		<1%	1,489	$41K
76870		<1%	1,074	$41K
82805		<1%	4,870	$40K
58661		<1%	18	$40K
76882		<1%	961	$40K
83970		<1%	3,458	$39K
86902		<1%	1,335	$39K
72131		<1%	1,862	$38K
81003		<1%	8,976	$38K
77295		<1%	59	$37K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	514	$37K
88142		<1%	2,860	$37K
88341		<1%	3,325	$37K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	7,046	$37K
84439		<1%	8,000	$37K
84702		<1%	7,987	$36K
81000		<1%	5,658	$35K
76885		<1%	405	$35K
82570		<1%	7,806	$35K
82784		<1%	6,496	$35K
73222		<1%	89	$35K
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	21,093	$35K
88342		<1%	4,896	$35K
82607		<1%	6,740	$34K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	4,450	$34K
81002		<1%	4,391	$34K
77072		<1%	967	$33K
77063	Screening digital breast tomosynthesis, bilateral	<1%	2,411	$33K
92555		<1%	5,673	$33K
L8613	Ossicula implant	<1%	1,407	$33K
73060		<1%	1,837	$32K
88304		<1%	1,637	$32K
82565		<1%	4,192	$32K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	324	$32K
Q5115	Injection, rituximab-abbs, biosimilar, (truxima), 10 mg	<1%	20	$32K
73700		<1%	464	$32K
96450		<1%	126	$32K
10060		<1%	567	$31K
85730		<1%	9,032	$31K
72156		<1%	444	$31K
12011		<1%	555	$30K
96417		<1%	2,293	$30K
86355		<1%	1,702	$29K
44970		<1%	13	$29K
96401		<1%	760	$29K
A0431	Ambulance service, conventional air services, transport, one way (rotary wing)	<1%	32	$28K
70498		<1%	1,844	$28K
J1756	Injection, iron sucrose, 1 mg	<1%	1,076	$28K
47562		<1%	17	$27K
94726		<1%	3,337	$26K
86359		<1%	2,366	$26K
83036	Hemoglobin; glycosylated (A1C)	<1%	9,922	$26K
99152		<1%	4,464	$26K
85652		<1%	14,534	$26K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	5,551	$25K
12001		<1%	493	$24K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	4,447	$24K
93451		<1%	58	$24K
73620		<1%	1,439	$24K
77062		<1%	649	$24K
C1726	Catheter, balloon dilatation, non-vascular	<1%	431	$23K
C1893	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away	<1%	591	$23K
L3933	Finger orthosis, without joints, may include soft interface, custom fabricated, includes fitting and adjustment	<1%	237	$23K
87186		<1%	8,143	$23K
86780		<1%	4,945	$23K
73120		<1%	846	$23K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	370	$23K
75574		<1%	313	$22K
99153	Mod sedat endo service >5yrs	<1%	3,363	$22K
87400		<1%	1,778	$22K
J1170	Injection, hydromorphone, up to 4 mg	<1%	8,185	$22K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	9,083	$21K
86833		<1%	1,857	$21K
86870		<1%	682	$21K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	4,357	$21K
83615		<1%	6,537	$21K
82105		<1%	2,042	$20K
96376		<1%	5,162	$20K
93225		<1%	962	$20K
77412		<1%	356	$20K
20610		<1%	423	$20K
87486		<1%	816	$19K
82378		<1%	1,851	$19K
0099U		<1%	433	$19K
70250		<1%	561	$19K
92611		<1%	1,641	$19K
72158		<1%	242	$19K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	2,454	$18K
77080		<1%	642	$18K
0097U		<1%	192	$18K
82330		<1%	2,641	$18K
77049		<1%	85	$18K
95819		<1%	141	$18K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	2,960	$17K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	11,480	$17K
96411		<1%	1,654	$17K
87799		<1%	4,443	$17K
73660		<1%	601	$17K
82550		<1%	4,089	$17K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	974	$17K
86923		<1%	1,919	$17K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	3,187	$17K
87040		<1%	4,173	$17K
64450		<1%	500	$17K
85014		<1%	3,783	$17K
94762		<1%	2,436	$16K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	4,430	$16K
54163		<1%	12	$16K
L3702	Elbow orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment	<1%	75	$16K
87210		<1%	3,328	$16K
72070		<1%	831	$16K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	6,496	$15K
78306		<1%	111	$15K
96416		<1%	577	$15K
A0427	Emergency ambulance ride, advanced life support	<1%	86	$15K
29888		<1%	14	$15K
J9202	Goserelin acetate implant, per 3.6 mg	<1%	155	$15K
J2550	Injection, promethazine hcl, up to 50 mg	<1%	3,476	$15K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	707	$14K
74019		<1%	938	$14K
73522		<1%	694	$14K
72146		<1%	388	$14K
88185		<1%	991	$14K
97760		<1%	1,479	$14K
70481		<1%	129	$14K
93975		<1%	403	$14K
86803		<1%	5,639	$14K
0399T		<1%	83	$14K
94618		<1%	701	$14K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	4,005	$13K
83540		<1%	9,340	$13K
82140		<1%	2,089	$13K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	3,999	$13K
72128		<1%	629	$13K
87205		<1%	4,371	$13K
77002		<1%	607	$13K
77061		<1%	795	$13K
83550		<1%	9,122	$13K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	1,966	$13K
82043		<1%	4,022	$12K
84156		<1%	5,031	$12K
84145		<1%	2,970	$12K
92586		<1%	111	$12K
93270		<1%	424	$12K
86357		<1%	628	$12K
94729		<1%	4,465	$12K
77065	Tomosynthesis, mammo	<1%	719	$11K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	681	$11K
64415		<1%	446	$11K
80074		<1%	781	$11K
87430		<1%	1,926	$11K
J2505	Injection, pegfilgrastim, 6 mg	<1%	19	$11K
93926		<1%	349	$11K
75561		<1%	39	$11K
76937		<1%	820	$11K
87340		<1%	5,618	$11K
85379		<1%	4,000	$11K
C1889	Implantable/insertable device, not otherwise classified	<1%	347	$11K
93990		<1%	572	$10K
J3370	Injection, vancomycin hcl, 500 mg	<1%	2,346	$10K
86922		<1%	1,335	$10K
86317		<1%	2,489	$10K
C1758	Catheter, ureteral	<1%	620	$10K
84134		<1%	1,874	$10K
83655		<1%	807	$10K
95700		<1%	155	$10K
J9299	Injection, nivolumab, 1 mg	<1%	14	$10K
84550		<1%	7,573	$10K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	1,555	$10K
V2632	Posterior chamber intraocular lens	<1%	606	$10K
59025	Fetal non-stress test	<1%	122	$10K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,487	$10K
77001		<1%	460	$9K
87102		<1%	2,068	$9K
86829		<1%	2,796	$9K
J2060	Injection, lorazepam, 2 mg	<1%	2,227	$9K
82670		<1%	315	$9K
86235		<1%	1,479	$9K
97014		<1%	25	$9K
93880		<1%	227	$9K
80320		<1%	1,933	$9K
86308		<1%	1,067	$9K
93321		<1%	5,838	$9K
72157		<1%	166	$9K
12002		<1%	235	$9K
82247		<1%	335	$9K
J9045	Injection, carboplatin, 50 mg	<1%	582	$8K
92626		<1%	95	$8K
A9585	Injection, gadobutrol, 0.1 ml	<1%	8,044	$8K
92604		<1%	258	$8K
54300		<1%	15	$8K
72081		<1%	186	$8K
82950		<1%	788	$8K
77338		<1%	135	$8K
83020		<1%	1,991	$8K
83516		<1%	2,332	$8K
74160		<1%	103	$8K
J0897	Injection, denosumab, 1 mg	<1%	48	$7K
92652		<1%	188	$7K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	3,793	$7K
82785		<1%	718	$7K
C9399	Unclassified drugs or biologicals	<1%	1,995	$7K
82746		<1%	3,170	$7K
88108		<1%	2,279	$7K
52332		<1%	28	$7K
85048		<1%	502	$7K
82657		<1%	14	$7K
86762		<1%	1,760	$7K
87116		<1%	1,610	$7K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	826	$7K
A9581	Injection, gadoxetate disodium, 1 ml	<1%	137	$7K
85045		<1%	7,275	$7K
88311		<1%	798	$7K
64490		<1%	14	$7K
73200		<1%	102	$7K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	1,724	$7K
43249		<1%	15	$6K
84153		<1%	1,544	$6K
G0390	Trauma response team associated with hospital critical care service	<1%	46	$6K
99201		<1%	115	$6K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	785	$6K
87536		<1%	559	$6K
86480		<1%	1,768	$6K
82150		<1%	1,194	$6K
97164		<1%	115	$6K
85347		<1%	1,091	$6K
77014		<1%	295	$6K
87206		<1%	1,602	$6K
92650		<1%	97	$6K
73020		<1%	352	$6K
92582		<1%	682	$6K
51701		<1%	728	$6K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	3,981	$6K
86920		<1%	424	$6K
11045		<1%	39	$5K
J1815	Injection, insulin, per 5 units	<1%	1,262	$5K
86039		<1%	1,879	$5K
90715		<1%	1,730	$5K
87522	Neg quan hep c or qual rna	<1%	667	$5K
88312		<1%	1,320	$5K
72190		<1%	169	$5K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	2,214	$5K
J3480	Injection, potassium chloride, per 2 meq	<1%	1,250	$5K
J3262	Injection, tocilizumab, 1 mg	<1%	74	$5K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	2,053	$5K
87075		<1%	453	$5K
30930		<1%	27	$5K
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	1,067	$5K
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	435	$5K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	668	$5K
86644		<1%	1,078	$5K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	1,110	$5K
73551		<1%	168	$5K
J1750	Injection, iron dextran, 50 mg	<1%	13	$5K
87581		<1%	815	$5K
96112		<1%	17	$5K
87807		<1%	340	$5K
64400		<1%	88	$5K
73501		<1%	308	$5K
84132		<1%	1,422	$4K
84295		<1%	1,327	$4K
95012		<1%	443	$4K
80165		<1%	569	$4K
82977		<1%	3,668	$4K
97750		<1%	280	$4K
85660		<1%	1,492	$4K
87305		<1%	1,630	$4K
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	722	$4K
J2997	Injection, alteplase recombinant, 1 mg	<1%	224	$4K
86828		<1%	478	$4K
A0436	Rotary wing air mileage, per statute mile	<1%	32	$4K
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	1,024	$4K
84703		<1%	1,911	$4K
70360		<1%	190	$4K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	615	$4K
83883		<1%	1,527	$3K
J1630	Injection, haloperidol, up to 5 mg	<1%	796	$3K
84403		<1%	1,176	$3K
88184		<1%	737	$3K
86160		<1%	1,754	$3K
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	452	$3K
77370		<1%	49	$3K
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	230	$3K
85520		<1%	569	$3K
J3471	Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)	<1%	264	$3K
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	869	$3K
84165		<1%	1,412	$3K
73562		<1%	190	$3K
80164		<1%	516	$3K
64445		<1%	163	$3K
93320		<1%	2,793	$3K
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	238	$3K
77073		<1%	125	$3K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	543	$3K
75635		<1%	29	$3K
86880		<1%	110	$3K
86905		<1%	573	$3K
80177		<1%	849	$3K
86665		<1%	1,111	$3K
87184		<1%	1,368	$3K
77290		<1%	15	$3K
92610		<1%	26	$3K
C2617	Stent, non-coronary, temporary, without delivery system	<1%	326	$3K
85384		<1%	1,485	$3K
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	<1%	959	$3K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	710	$3K
83001		<1%	717	$2K
76377		<1%	15	$2K
62328		<1%	14	$2K
88313		<1%	1,173	$2K
81378		<1%	125	$2K
84480		<1%	1,089	$2K
82375		<1%	1,651	$2K
84146		<1%	276	$2K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	95	$2K
83050		<1%	1,654	$2K
86787		<1%	989	$2K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	698	$2K
86706		<1%	409	$2K
82962		<1%	821	$2K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	391	$2K
94642		<1%	119	$2K
86704		<1%	1,329	$2K
81373		<1%	90	$2K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	1,097	$2K
C1729	Catheter, drainage	<1%	215	$2K
86225		<1%	972	$2K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	291	$2K
90686		<1%	496	$2K
82085		<1%	418	$2K
36512		<1%	15	$2K
76827		<1%	815	$2K
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	199	$2K
80195		<1%	667	$2K
72195		<1%	14	$2K
92585		<1%	78	$2K
A4648	Tissue marker, implantable, any type, each	<1%	29	$2K
Q9961	High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml	<1%	594	$2K
C1760	Closure device, vascular (implantable/insertable)	<1%	17	$2K
62321		<1%	13	$2K
96377		<1%	20	$2K
71271		<1%	45	$2K
93886		<1%	44	$2K
86146		<1%	84	$2K
J2785	Injection, regadenoson, 0.1 mg	<1%	471	$2K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	61	$2K
93460		<1%	13	$2K
36600		<1%	207	$1K
83520		<1%	208	$1K
73718		<1%	19	$1K
82533		<1%	408	$1K
85018		<1%	346	$1K
86592		<1%	169	$1K
86360		<1%	1,161	$1K
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	1,022	$1K
86431		<1%	784	$1K
80321		<1%	403	$1K
J7999	Compounded drug, not otherwise classified	<1%	195	$1K
92522		<1%	28	$1K
J9190	Injection, fluorouracil, 500 mg	<1%	86	$1K
99195		<1%	578	$1K
84630		<1%	981	$1K
72120		<1%	56	$1K
86256		<1%	1,074	$1K
82397		<1%	480	$1K
83930		<1%	575	$1K
81376		<1%	147	$1K
76857		<1%	37	$1K
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	208	$1K
82610		<1%	276	$1K
71101		<1%	52	$1K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	41	$1K
76800		<1%	12	$1K
G8982	Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	110	$1K
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	78	$1K
85246		<1%	58	$1K
84446		<1%	622	$1K
84590		<1%	681	$1K
J3489	Injection, zoledronic acid, 1 mg	<1%	68	$1K
87420		<1%	32	$1K
0296T		<1%	67	$984.25
72050		<1%	26	$960.13
84311		<1%	124	$959.17
70355		<1%	31	$905.74
0297T		<1%	13	$898.64
G8981	Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	85	$885.27
86301		<1%	203	$876.99
88173		<1%	323	$866.18
82270		<1%	716	$857.52
86481		<1%	101	$857.22
84300		<1%	104	$822.74
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	136	$813.91
89230		<1%	28	$811.24
82077		<1%	2,378	$780.12
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	642	$764.33
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	35	$738.57
81374		<1%	16	$718.46
86003		<1%	377	$713.31
83521		<1%	511	$706.68
80175		<1%	230	$705.38
87493		<1%	13	$703.59
82945		<1%	527	$671.17
29515		<1%	41	$668.36
80323		<1%	308	$661.20
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	308	$647.79
74170		<1%	17	$643.07
84157		<1%	550	$635.13
94621		<1%	14	$630.82
86255		<1%	36	$630.54
86352		<1%	31	$617.70
72080		<1%	35	$614.96
C1762	Connective tissue, human (includes fascia lata)	<1%	199	$594.98
82103		<1%	48	$591.77
80202		<1%	62	$582.94
84520		<1%	137	$576.43
86334		<1%	409	$574.20
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	484	$568.75
J8540	Dexamethasone, oral, 0.25 mg	<1%	1,269	$550.33
84450		<1%	464	$549.98
80051		<1%	116	$541.89
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	216	$538.10
J1940	Injection, furosemide, up to 20 mg	<1%	754	$524.78
80143		<1%	787	$513.95
J0456	Injection, azithromycin, 500 mg	<1%	97	$502.19
C1780	Lens, intraocular (new technology)	<1%	500	$493.87
29125		<1%	66	$493.81
91010		<1%	16	$485.52
86769		<1%	156	$462.53
85613		<1%	233	$453.71
82040		<1%	17	$445.22
97763		<1%	87	$441.67
86376		<1%	452	$425.87
J1953	Injection, levetiracetam, 10 mg	<1%	539	$424.31
73650		<1%	37	$416.47
80349		<1%	26	$411.16
A4649	Surgical supply; miscellaneous	<1%	151	$409.60
84425		<1%	584	$405.77
80299		<1%	18	$382.35
J7510	Prednisolone oral, per 5 mg	<1%	1,773	$382.12
64447		<1%	13	$378.39
84155		<1%	576	$364.52
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	14	$363.92
87181		<1%	133	$344.89
72202		<1%	12	$333.84
G8997	Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	82	$332.13
G8996	Swallowing functional limitation, current status at therapy episode outset and at reporting intervals	<1%	82	$332.13
83010		<1%	338	$319.84
62270		<1%	14	$312.86
C1773	Retrieval device, insertable (used to retrieve fractured medical devices)	<1%	68	$307.76
81382		<1%	28	$303.34
85240		<1%	67	$302.80
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	154	$299.06
51798		<1%	201	$298.14
87517		<1%	85	$291.23
95874		<1%	212	$288.79
A0425	Ground mileage, per statute mile	<1%	963	$285.33
76942		<1%	28	$277.48
82088		<1%	43	$257.27
94728		<1%	31	$254.11
82010		<1%	744	$253.88
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	1,215	$250.27
92526		<1%	16	$245.52
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	13	$244.17
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	<1%	46	$235.57
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	16	$235.46
70470		<1%	18	$224.82
84207		<1%	360	$222.00
86708		<1%	191	$219.58
83002		<1%	333	$216.89
84305		<1%	126	$203.06
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	28	$193.70
86200		<1%	269	$193.56
C9113	Injection, pantoprazole sodium, per vial	<1%	449	$191.26
Q9956	Injection, octafluoropropane microspheres, per ml	<1%	113	$184.35
94750		<1%	53	$181.34
J9370	Vincristine sulfate, 1 mg	<1%	325	$174.37
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	176	$174.13
85097		<1%	51	$170.50
87529		<1%	28	$170.37
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	77	$169.99
72192		<1%	17	$157.03
88300		<1%	103	$153.06
81050		<1%	145	$145.26
87631		<1%	76	$139.18
84460		<1%	147	$135.96
86664		<1%	25	$130.06
86694		<1%	86	$129.89
74022		<1%	32	$119.88
J9263	Injection, oxaliplatin, 0.5 mg	<1%	38	$116.68
86356		<1%	168	$105.87
G8998	Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	31	$104.91
85576		<1%	45	$102.14
72220		<1%	14	$99.29
94799		<1%	25	$97.39
80179		<1%	694	$96.62
84270		<1%	157	$87.16
86147		<1%	115	$80.41
82525		<1%	106	$77.36
91038		<1%	14	$75.05
64636		<1%	210	$74.01
94727		<1%	17	$70.24
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	42	$65.76
86304		<1%	20	$63.76
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	12	$63.59
86800		<1%	25	$49.66
84244		<1%	69	$43.31
J9267	Injection, paclitaxel, 1 mg	<1%	51	$43.02
C1788	Port, indwelling (implantable)	<1%	29	$43.02
86364		<1%	261	$35.83
87106		<1%	96	$32.19
64494		<1%	192	$30.78
J9070	Cyclophosphamide, 100 mg	<1%	19	$29.80
J9250	Methotrexate sodium, 5 mg	<1%	473	$24.90
97016		<1%	43	$22.85
84681		<1%	28	$20.93
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	59	$16.44
J0461	Injection, atropine sulfate, 0.01 mg	<1%	17	$14.34
83935		<1%	13	$11.95
82627		<1%	27	$11.52
82104		<1%	30	$7.24
86777		<1%	22	$6.72
82310		<1%	15	$3.13
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	36	$3.11
85732		<1%	190	$1.25
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	0%	35	$0.00
80230		0%	104	$0.00
84478		0%	40	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	54	$0.00
82438		0%	28	$0.00
88364		0%	24	$0.00
86695		0%	18	$0.00
85397		0%	28	$0.00
J3411	Injection, thiamine hcl, 100 mg	0%	41	$0.00
87625		0%	17	$0.00
J3360	Injection, diazepam, up to 5 mg	0%	15	$0.00
J1610	Injection, glucagon hydrochloride, per 1 mg	0%	13	$0.00
86381		0%	16	$0.00
85032		0%	15	$0.00
C1781	Mesh (implantable)	0%	15	$0.00
J0713	Injection, ceftazidime, per 500 mg	0%	28	$0.00
94760		0%	20	$0.00
82360		0%	18	$0.00
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	0%	562	$0.00
23350		0%	32	$0.00
89050		0%	30	$0.00
87107		0%	37	$0.00
88237		0%	55	$0.00
88302		0%	19	$0.00
C1776	Joint device (implantable)	0%	29	$0.00
38222		0%	14	$0.00
86696		0%	18	$0.00
86015		0%	22	$0.00
88262		0%	53	$0.00
64616		0%	15	$0.00
88365		0%	25	$0.00
J0735	Injection, clonidine hydrochloride, 1 mg	0%	14	$0.00
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	0%	18	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHOLMES, MICHAEL (CEO)

Same official

Other billing entities under HOLMES, MICHAEL

Full network →

Provider	Location	Paid
Shands Teaching Hospital and Clinics INC	Gainesville, FL	$17.74M
West Side Sober Living	Minnetonka, MN	$5.21M
Pediatric Dental Associates	Gadsden, AL	$2.42M
Shands Teaching Hospital and Clinics INC	Gainesville, FL	$91K
Shands Teaching Hospital and Clinics INC	Gainesville, FL	$25K
Shands Teaching Hospital and Clinics INC	Gainesville, FL	$24K
Shands Teaching Hospital and Clinics INC	Gainesville, FL	$13K
Shands Teaching Hospital and Clinics INC	Gainesville, FL	$3K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.